(Q36947032)

17 August 2017

1 reference

title

Standard and novel therapeutic approaches to Behçet's disease (English)

1 reference

17 August 2017

0 references

Ahmet Gul

1

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

67

1 reference

17 August 2017

14

1 reference

17 August 2017

2013-2022

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767140-00004

17 August 2017

0 references

cites work

A controlled trial of azathioprine in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767140-00004

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767140-00004

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767140-00004

Treatment of Behcet disease with chlorambucil. A follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767140-00004

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767140-00004

Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study

21 January 2018

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

1 reference

12 December 2020

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

1 reference

12 December 2020

The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial

1 reference

12 December 2020

Cyclosporine neurotoxicity: a review

1 reference

12 December 2020

Short-term chlorambucil for refractory uveitis in Behcet's disease

1 reference

12 December 2020

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

1 reference

12 December 2020

Pulmonary artery aneurysms in Behçet syndrome

1 reference

12 December 2020

Pulmonary manifestations of Behçet's disease

1 reference

12 December 2020

Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

1 reference

12 December 2020

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

12 December 2020

Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

1 reference

12 December 2020

A double-blind trial of depot corticosteroids in Behçet's syndrome

1 reference

12 December 2020

A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis

1 reference

12 December 2020

Evaluation of diagnostic ('classification') criteria in Behçet's disease--towards internationally agreed criteria. The International Study Group for Behçet's disease

1 reference

12 December 2020

Treatment of Behcet's syndrome

1 reference

12 December 2020

Pharmacotherapy for Behcet's syndrome

1 reference

12 December 2020

Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis

1 reference

12 December 2020

1 reference

12 December 2020

Behçet's disease as an autoinflammatory disorder

1 reference

12 December 2020

Seven-year follow-up of neurologic involvement in Behçet syndrome

1 reference

12 December 2020

The management of Behçet's syndrome: how are we doing?

1 reference

12 December 2020

T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease

1 reference

12 December 2020

A double blind study of colchicine in Behçet's disease

1 reference

12 December 2020

Immunology and functional genomics of Behçet's disease

1 reference

12 December 2020

Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial

1 reference

12 December 2020

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.

1 reference

12 December 2020

Neovascularization of the optic disc in Behçet's disease

1 reference

12 December 2020

The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Behçet's disease: an update on the pathogenesis

1 reference

12 December 2020

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease

1 reference

12 December 2020

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

1 reference

12 December 2020

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

1 reference

12 December 2020

Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial.

1 reference

12 December 2020

A double-blind trial of colchicine in Behçet's syndrome

1 reference

12 December 2020

Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.

1 reference

12 December 2020

Azathioprine in Behcet's syndrome: effects on long-term prognosis

1 reference

12 December 2020

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

1 reference

12 December 2020

Lack of association of HLA-B*51 with a severe disease course in Behçet's disease

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

10.2165/00003495-200767140-00004

Identifiers

DOI

1 reference

PubMed ID

17883285

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17883285